Sexual dysfunction in males with concomitant urological diseases
- Authors: Al-Shukri SK.1, Korneev IA1
-
Affiliations:
- Issue: No 3 (2005)
- Pages: 18-22
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/276347
- ID: 276347
Cite item
Full Text
Abstract
A clinical data was studied for 117 males without complaints for copulative disorders admitted to urological clinic electively for benign prostatic hyperplasia (BPH) - 44 (37.6%), urolithiasis - 25 (21.4%), external genital diseases - 17(14.5%), renal cyst and hydronephrosis - 16(13.7%), renal and vesical tumors - 15(12.8%). Mean age of the patients was 56.2 ±16.1 years. The patients filled
in IPSS and IIEF questionnaires. Mean score set (±SD) for IIEF and IPSS was 35 + 23 and 12 + 10, respectively. The majority of the patients (n = 61) were not sexually active. Erectile dysfunction (ED) was detected in 23 (19.7%) patients: mild and moderate in 19 (16.2%) and 4 (3.4%), respectively). 24 (73%) patients with normal erectile function, 10 (44%) patients with ED and the majority (n = 37) of sexually inactive men were satisfied with their sexual activity. Those males who needed improvement of sexual life quality had higher (p < 0.05) parameters of erectile function and sexual satisfaction. Age of the patients (R2 = 33.l;p< 0.0001) and IPSS index (p < 0.015) were leading indices in determining condition of the copulative function. IIEF correlated with tumors of the kidney or urinary bladder (p < 0.004) and benign prostatic hyperplasia (p < 0.015). Erectile dysfunction in men with urological diseases was closely related with age and severity of lower urinary tract symptoms. Other sexual disorders may be due both to general causes and urological diseases.
in IPSS and IIEF questionnaires. Mean score set (±SD) for IIEF and IPSS was 35 + 23 and 12 + 10, respectively. The majority of the patients (n = 61) were not sexually active. Erectile dysfunction (ED) was detected in 23 (19.7%) patients: mild and moderate in 19 (16.2%) and 4 (3.4%), respectively). 24 (73%) patients with normal erectile function, 10 (44%) patients with ED and the majority (n = 37) of sexually inactive men were satisfied with their sexual activity. Those males who needed improvement of sexual life quality had higher (p < 0.05) parameters of erectile function and sexual satisfaction. Age of the patients (R2 = 33.l;p< 0.0001) and IPSS index (p < 0.015) were leading indices in determining condition of the copulative function. IIEF correlated with tumors of the kidney or urinary bladder (p < 0.004) and benign prostatic hyperplasia (p < 0.015). Erectile dysfunction in men with urological diseases was closely related with age and severity of lower urinary tract symptoms. Other sexual disorders may be due both to general causes and urological diseases.
References
- Andersson К. Е., Wagner G. Physiology of erection. Physiol. Rev. 1995; 75: 191-236.
- Christ G. J. The penis as a vascular organ. Urol. Clin. N. Am. 1995; 75: 727-745.
- Hanash K. A. Comparative results of goal oriented therapy for erectile dysfunction. J. Urol. (Baltimore) 1997; 157: 2135- 2138.
- Heaton J., Hackett G. I., Savage D., Pauley R. J. Patient choice is critical in managing erectile dysfunction. Eur. Urol. 2002; 1 (3): 33-37.
- Jardin A., Wagner G., Khoury S. et al., eds. Recommendations of the First International Consultation on Erectile Dysfunction, cosponsored by the World Health Organization (WHO). Plymouth: Health Publications Ltd.; 2000. 709-726.
- Feldman H. A., Goldstein I., Hatzichristou D. G. et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J. Urol. (Baltimore) 1994; 151: 54-61.
- Martin-Morales A., Sanchez-Cruz J. J., Saenz de Tejada I. et al. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfunction Erectil Masculina Study. J. Urol. (Baltimore) 2001; 166: 569-575.
- Parazzini F., Menchini Fabris F., Borolotti A. et al. Frequency and determinants of erectile dysfunction in Italy. Eur. Urol. 2000; 37: 43-49.
- Lewis R. W., Hatzichristou D. G., Laumann E., McKinlay J. B. Epidemiology and natural history of erectile dysfunction: risk factors including iatrogenic and ageing. In: Jardin A., Wagner G., Khoury S. et al., eds. Recommendations of the First International Consultation on Erectile Dysfunction, cosponsored by World Health Organization (WHO). Plymouth: Health Publication Ltd.; 2000. 21-51.
- Weiss J. N., Baldani G. H., Ravalli Cum R., Brettschneider Curn N. Reasons for high drop-out rate with self-injection therapy for impotence. Int. J. Impot. Res. 1994; 6: 171 - 174.
- Casabe A., Cobreros C., Bechara A. et al. Drop out reason in responded to sildenafil. Int. J. Impot. Res. 2001; 13 (suppl. 2): S3.
- Riley A. The role of the partner in erectile dysfunction and its treatment. Int. J. Impot. Res. 2002; 14 (suppl. 1): S105-S109.
- Barry M. J., Fowler F. J. Jr., O'Leary M. P. et al. for the Measurement Committee of the American Urological Association. The American Urological Association symptom index for benign prostatic hyperplasia. J. Urol. (Baltimore) 1992; 148: 1549-1564.
- Rosen R. C., Riley A., Wagner G. et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830.
- Litwin M. S., Med R. J., Dhanani N. Health-related quality of life in men with erectile dysfunction. J. Gen. Intern. Med. 1998; 13: 159-166.
- Wagner G., Fugl-Meyer A. R. Impact of erectile dysfunction on quality of life: patient and partner perspectives. Int. J. Impot. Res. 2000; 12 (suppl. 4): 144-146.
Supplementary files
